secwatch.observer — SEC 8-K summary
======================================

Issuer:     IMMUNIC, INC. (IMUX)
CIK:        0001280776
Form:       8-K
Filed at:   2025-06-04T23:59:59+00:00
Accession:  0001193805-25-000787
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Immunic shareholders approve 7M share increase in equity plan, elect three Class II directors
--------------------------------------------------------------------------------

- Plan amendment increases authorized shares by 7,000,000 to 26,448,871; approved with 32,765,299 for, 10,731,124 against.
- Dr. Jörg Neermann, Tamar Howson, and Barclay Phillips elected as Class II directors until 2028.
- Baker Tilly US, LLP ratified as independent auditor for fiscal 2025 with 60,427,763 votes for.
- Quorum of 61,229,143 shares (63.9% of outstanding) present at June 4, 2025 annual meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1280776/000119380525000787/0001193805-25-000787-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1280776/000119380525000787/e664589_8k-immunic.htm
  HTML page:      https://secwatch.observer/filing/0001193805-25-000787

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer